Literature DB >> 12468535

Negative regulation of ERK and Elk by protein kinase B modulates c-Fos transcription.

Ivana Galetic1, Sauveur-Michel Maira, Mirjana Andjelkovic, Brian A Hemmings.   

Abstract

In this study, we have identified novel regulatory steps involved in the cross-talk between protein kinase B (PKB) and MAPK signaling pathways. We found that PKB down-regulates the Ras-Raf-MEK-ERK pathway by reducing the activity of ERK, which leads to inactivation of the transcription factor Elk1. In addition, PKB is able to reduce protein levels of Elk1. Both events lead to suppression of serum response element (SRE)-dependent transcription and a consequent decrease in the transcription of SRE-containing genes, such as c-fos. Because activation of the Ras/MAPK cascade is reported to increase c-fos transcription before apoptosis, our results are consistent with a specific role for PKB in promoting cell survival. Decrease in c-Fos protein levels in glioblastoma cells with constitutively active PKB provides further support for our observations. Therefore, our findings delineate a novel mechanism regulating immediate-early transcription, which may be involved in the initial steps in PKB-induced oncogenic transformation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468535     DOI: 10.1074/jbc.M210578200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.

Authors:  Marianne Gervais; Céline Dugourd; Laurent Muller; Corinne Ardidie; Brigitte Canton; Laetitia Loviconi; Pierre Corvol; Hervé Chneiweiss; Catherine Monnot
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

Review 2.  Complexity in interpretation of embryonic epithelial-mesenchymal transition in response to transforming growth factor-beta signaling.

Authors:  Shaheen Ahmed; Ali Nawshad
Journal:  Cells Tissues Organs       Date:  2007       Impact factor: 2.481

3.  Rapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agents.

Authors:  Tiffany A Kolniak; Jack M Sullivan
Journal:  Exp Eye Res       Date:  2011-01-21       Impact factor: 3.467

4.  Suppression of Egr-1 transcription through targeting of the serum response factor by oncogenic H-Ras.

Authors:  Soon Young Shin; Young Yil Bahk; Jesang Ko; Il-Yup Chung; Young Seek Lee; Julian Downward; Hermann Eibel; Prem M Sharma; Jerrold M Olefsky; Young-Ho Kim; Bonghee Lee; Young Han Lee
Journal:  EMBO J       Date:  2006-02-02       Impact factor: 11.598

5.  H3 histamine receptor agonist inhibits biliary growth of BDL rats by downregulation of the cAMP-dependent PKA/ERK1/2/ELK-1 pathway.

Authors:  Heather Francis; Antonio Franchitto; Yoshiyuki Ueno; Shannon Glaser; Sharon DeMorrow; Julie Venter; Eugenio Gaudio; Domenico Alvaro; Giammarco Fava; Marco Marzioni; Bradley Vaculin; Gianfranco Alpini
Journal:  Lab Invest       Date:  2007-03-05       Impact factor: 5.662

6.  Akt inhibitor a-443654 interferes with mitotic progression by regulating aurora a kinase expression.

Authors:  Xuesong Liu; Yan Shi; Keith W Woods; Paul Hessler; Paul Kroeger; Julie Wilsbacher; Jieyi Wang; Jean Y Wang; Chunying Li; Qun Li; Saul H Rosenberg; Vincent L Giranda; Yan Luo
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

Review 7.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

Authors:  Yohannes Mebratu; Yohannes Tesfaigzi
Journal:  Cell Cycle       Date:  2009-04-11       Impact factor: 4.534

8.  The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt.

Authors:  P R Somanath; J Vijai; J V Kichina; T Byzova; E S Kandel
Journal:  Oncogene       Date:  2009-05-04       Impact factor: 9.867

9.  Propofol-induced changes in neurotrophic signaling in the developing nervous system in vivo.

Authors:  Jelena Popic; Vesna Pesic; Desanka Milanovic; Smilja Todorovic; Selma Kanazir; Vesna Jevtovic-Todorovic; Sabera Ruzdijic
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

10.  Alternatively spliced isoforms of the human elk-1 mRNA within the 5' UTR: implications for ELK-1 expression.

Authors:  Tanguy Araud; Raphael Genolet; Pascale Jaquier-Gubler; Joseph Curran
Journal:  Nucleic Acids Res       Date:  2007-06-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.